| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-315 |
| filingDate |
2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f221fdda03677ff5c0cbf25939cfe2e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165ad81b34292fe27a70538e7c83dfcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c722ba5ba5bad423a0c3b0d10000c0ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_643929a30f0772e8bd8dfa894c8aaa39 |
| publicationDate |
2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2001031785-A1 |
| titleOfInvention |
Use of zinc tranexamate in the treatment of diabetes |
| abstract |
A new use of a zinc tranexamate compound in the treatment of diabetes is disclosed. Oral administration of the compound adequately slows down absorption of glucose from digestive tracts by inhibiting α-glucosidase in vivo. The zinc tranexamate compound is also effective in the treatment of insulin-resistant type II diabetes. |
| priorityDate |
2000-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |